Rafiye ÇİFTÇİLER, Erdinç ÇİFTÇİLER, Arzu AYHAN, Yahya BÜYÜKAŞIK

Follow-up of Patients with Atypical Lymphoproliferation in Bone Marrow or Lymph Node Biopsy

Objective: Patients presenting with various complaints to the hematology polyclinic may initially be diagnosed with an atypical lymphoproliferation in bone marrow or lymph node biopsy. The aim of this study was to determine whether a hematological disease, immunodeficiency syndrome, or other diseases were diagnosed during follow-up of patients with an initial diagnosis of atypical lymphoproliferation in bone marrow or in lymph node biopsy. Materials and Methods: Adult (≥18 years) patients who were admitted to the Hacettepe University Hospital, for various symptoms between 2002 and 2018 were searched for in our hematology department electronical database. Results: A total of 52 patients were found with atypical lymphoproliferation in lymph node or bone marrow biopsy. The patients had been followed for a median of 9.2 months (0.03-86.2). Hematological neoplasia developed in 32 (61.6%) of the 52 patients and primary immunodeficiency was detected in 6 (11.5%) of the 52 patients. Twenty-six patients (50%) were diagnosed Non-Hodgkin lymphoma during follow up, 1 patient (1%) was diagnosed chronic lymphocytic leukemia, 5 patients (9.6%) were diagnosed Hodgkin lymphoma and 6 patients (11.5%) were diagnosed primary immunodeficiency. Median time was 2.3 months (0.2-25 months) between atypical lymphoproliferation report in bone marrow or lymph node biopsy and the diagnosis of patients. Conclusion: In conclusion, patients who have atypical lymphoproliferation in the lymph node or bone marrow biopsy should be followed up in the hematology outpatient clinic. Because, during follow-up, diseases such as hematological neoplasia or immunodeficiency can be diagnosed in patients with atypical lymphoproliferation.

PDF

___

[1]Knutsson A, Jonsson B, Akerstedt T, et al. Increased risk of ischaemic heart disease in shift workers. The Lancet 1986; 2(8498): 89-92.

[2]Kawachi I, Colditz GA, Stampfer MJ, et al. Prospective study of shift work and risk of coronary heart disease in women. Circulation 1995; 92(11): 3178-82.

[3]Bøggild H, Knutsson A. Shift work, risk factors and cardiovascular disease. Scandinavian journal of work, environment & health. 1999; 25(2): 85-99.

[4]Ferrario MM, Veronesi G, Bertù L, et al. Job strain and the incidence of coronary heart diseases: does the association differ among occupational classes? A contribution from a pooled analysis of Northern Italian cohorts. BMJ open. 2017; 7(1): e014119.

[5]Dragano N, Siegrist J, Nyberg ST, et al. Effort–reward imbalance at work and incident coronary heart disease: a multicohort study of 90,164 individuals. Epidemiology (Cambridge, Mass.). 2017; 28(4): 619-26.

[6]Vrijkotte TG, Van Doornen LJ, De Geus EJ. Effects of work stress on ambulatory blood pressure, heart rate, and heart rate variability. Hypertension 2000; 35(4): 880-6.

[7]Ha M, Kım J, Park J, et al. Blood pressure and heart rate variability in workers of 8-hour shifts. Journal of Human Ergology 2001; 30(1-2): 229-33.

[8]Berntson GG, Thomas Bigger Jr J, Eckberg DL, et al. Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology 1997; 34: 6623-48.

[9]Cardiology ESo. the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use; Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996; 93(5): 1043-65.

[10]Stein PK, Kleiger RE. Insights from the study of heart rate variability. Annu Rev Med 1999; 50: 249-61.

[11]Malik M, Camm AJ. Components of heart rate variability--what they really mean and what we really measure. The American journal of cardiology 1993;72(11): 821-2.

[12]Ito H, Nozaki M, Maruyama T, et al. Shift work modifies the circadian patterns of heart rate variability in nurses. International journal of cardiology 2001; 79(2-): 3231-6.

[13]Slišković A, Manenica I. Changes in heart rate variability during working and non-working nights. Medica Jadertina 2011; 41(1-2): 15-22.

[14]Gamble KL, Berry R, Frank SJ, et al. Circadian clock control of endocrine factors. Nature Reviews Endocrinology 2014; 10(8): 466-75.

[15]Ueyama T, Krout KE, Van Nguyen X, et al. Suprachiasmatic nucleus: a central autonomic clock. Nature neuroscience 1999; 2(12): 1051-3.

[16]Furlan R, Barbic F, Piazza S, et al. Modifications of cardiac autonomic profile associated with a shift schedule of work. Circulation 2000; 102(16): 1912-6.

[17]Borchini R, Veronesi G, Bonzini M, et al. Heart rate variability frequency domain alterations among healthy nurses exposed to prolonged work stress. International journal of environmental research and public health 2018;113.